Jump to Footer

Shamima Khan

Assistant Professor of Pharmacy Administration
Department of Pharmaceutical & Administrative Sciences

Email:     shamima.khan@wne.edu
Phone:   413-796-2440
Office:    CSP 318


   Post-Doctoral Associate, Department of General Internal Medicine, College of Medicine, The University of Vermont, Burlington, VT
   Doctor of Philosophy, College of Pharmacy, the University of Louisiana at Monroe, Monroe, LA, Major: Pharmacy Administration/ Social and Administrative Sciences
   Master of Business Administration (AACSB Accredited), College of Business Administration, the University of Louisiana at Monroe, Monroe, LA, Major: Business Administration
   Bachelor of Science, College of Pharmacy, the University of Louisiana at Monroe, Monroe, LA, Major: Clinical Laboratory Science

Classes Taught

  • Health Care Policy & Delivery
  • Practice Management I
  • Social Aspects of Pharmacy Practice
  • Environment of Pharmaceutical Marketing
  • Introduction to Pharmacoeconomics
  • Retail Pharmacy Management
  • Pharmacy & US Health Care System
  • Financial Management
  • Pharmacoeconomics 
  • Managed Care
  • Statistics

Research Interests

   Health Policy, Community Pharmacy, Pharmacoeconomics, Public Health


Presentations/ Publications (Selected)

Peer Reviewed:

  • Khan S. Impact of Medicare Part D on Community Pharmacy: A multi-region, multi-state survey.  Accepted for a poster presentation at the ACCP Annual Meeting 2012 October 21-24; Hollywood, FL.

  • Khan S et al. Medicare Part D in Community Pharmacy: Continued Impact and Related Issues. Poster Session presented at: American College of Clinical Pharmacy (ACCP) Annual Meeting 2010 October 17-20; Austin, TX.

  • Khan S et al. Prevalence of food insecurity and utilization of food assistance program: an exploratory survey of a Vermont middle school. J Sch Health. 2011 Jan;81(1):15-20.

  • Khan S et al. The effect of the Vermont Diabetes Information System on inpatient and emergency room use: results from a randomized trial. Health Outcomes Res Med. 2010 Jul;1(1):e61-e66.

  • Khan S et al. Is There a Successful Business Case for Telepharmacy? Telemed J E Health. 2008;14(3):235-244.

  • Pitts B, Dominelli A, Khan S. Physician Patient Communication Regarding Medicare Part D in Two Midwestern States. P &T. 2007;32(10):544-546, 549-551. 

  • Lee AJ, Chiao TB, Lam JT, Khan S, Boro MS. Improving Medication Safety in the ICU: the Pharmacist’s Role. Hospital Pharmacy. 2007;42(4):337-344.  

  • Song JC, Wang CC, Huang Y, Sanchez J, Nguyen T, Khan S, Kim M, Li P. (2006). Use of Maximum-dose Simvastatin or Atorvastatin in an Ethnically Diverse Population.  Am J Health Syst Pharm.  2007;64(7):767-72.

  • Khan S et al. Predicting Future High Cost Asthma Patients (Recipients). J of Pharmaceutical Finance, Economics & Policy. 2005; 14(4):43-52.

  • Hoffmann-Smith KA, Khan S, Lewis SA. An Adverse Drug Phenomenon in Response to

  • Intrathecal Hydromorphone Administration. American J of Pain Management. 2005;15:82-87.

Non-Peer Reviewed:

  • Book Chapter: Schafemeyer KW, Khan S, Scott DM, Hurd PD: Managed Care Pharmacy and Public Health.  In: Hurd P, Lubotsky Levin B, and Hanson A. (editors). Chapter 9, Introduction to Public Health in Pharmacy, 1st edition, Jones and Barlett Publishers, Sudbury, MA: 205-225. 2008.


Hobbies and Other Interests

   Exercise and Traveling